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Abstract: The aim of this work was to study the peripheral blood monocyte functions in patients with advanced RA and 
their predisposed to RA relatives in comparison with those in women, not hereditary tainted with autoimmune diseases 
(donors). In groups comprising 24 RA patients, 24 relatives, and 24 donors the following monocyte functions were 
assessed: engulfment and digestion (radioisotope method); release of lysosomal glucuronidase in response to opsonized 
zymosan (fluorescent method); reactive oxygen species (ROS) generation (chemiluminescence), and serum levels of 
proinflammatory cytokines (ELISA). The monocyte specific feature in patients and their relatives is chiefly extracellular 
digestion due to the delayed engulfment. The digestive activity, probably inhibited in relatives, is increased in advanced 
RA. ROS generation by the cells and serum levels of TNF-alpha and IL-1-beta are abundant both in the patients and their 
relatives. 
High levels of pro-inflammatory cytokines, presumably, of monocyte origin, and increased levels of stimulated ROS 
generation may be due to the priming and prolonged activation of monocytes in relatives. 
Conclusion: We show for the first time that the functioning of circulating mononuclear phagocytes in the assumed to be 
healthy predisposed to RA individuals differs from that in the healthy people not hereditary tainted with autoimmune 
diseases and in general resembles the functioning of the cells in the patients with advanced RA. 
Keywords: Rheumatoid arthritis, relatives, monocytes, phagocytosis, cytokines. 
INTRODUCTION 
  For long the role of monocyte – macrophage system in 
the pathogenesis of rheumatoid arthritis (RA) remains an 
attractive research focus. Indeed, these cells are present in 
prominent number in the inflamed synovial membrane and at 
the cartilage – pannus junction since the very early stages of 
the disease [1-3]. Joint tissue macrophages are critically 
involved in the pathogenesis of RA. They are the primary 
source of the proinflammatory cytokines and chemokines in 
the inflammatory sites and contribute to the cartilage and 
bone destruction (reviewed by Bresnihan B. and by Ma Y., 
Pope R.M.) [3, 4]. The number of these cells in synovial 
lining layer at baseline correlates with the number of new 
erosions on radiographs of the hands and feet 1 year later 
and with the disease activity on all the stages of RA 
development [3, 5]. 
  As it was borne out again (this time – with the help of 
monocyte scintigraphy after the reinfusion of the labeled 
cells to the RA patients), the macrophages of the joint 
inflammatory sites are of vessel bed monocyte origin [6]. It 
is essential for the RA pathogenesis, that circulating 
monocytes are the precursors not only of tissue and 
inflammatory macrophages in rheumatoid joints, but of 
dendritic cells and osteoclasts as well, both known to be the 
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important players in the disease development (reviewed by 
Kinne R. W.) [7]. 
  It should be pointed out that by no means blood vessel 
monocytes should be interpreted as simple precursors of 
various joint tissue cells – the RA pathogenesis players. 
There is the well known evidence of a specific condition of 
the circulating monocytes – spontaneous production of 
prostanoids and prostaglandin E2, cytokines, soluble CD14, 
as the examples, and, more generally, gene activation with a 
pattern closely resembling the synovial activation pattern 
(reviewed by Kinne R.W., et al.) [8]. So, to the review 
author’s opinion, the circulating monocytes in RA appear to 
be preshaped in a “rheumatoid” phenotype before they entry 
into the inflamed synovial tissues. There is also the evidence 
of alteration of bone marrow myeloid precursors in RA 
patients [8]. So, the “rheumatoid” phenotype of the 
circulating monocytes may be a result of the specific 
exposure of their bone marrow precursors or the 
epiphenomenon of a central differentiation defect. 
  The data presented in this publication are the part of the 
long-term (more than 10 years) cohort study of rheumatoid 
arthritis (RA) and common infections relationship. The 
undertaken long term clinical monitoring of the RA patients 
and their first degree maternal relatives, generally accepted 
to be predisposed to the disease [1,11], showed that these 
individuals suffer from frequent and prolonged common 
infections that may a result of antiinfectious defense 
insufficiency, namely of it’s innate component (in press). Mononuclear Phagocytes in Rheumatoid Arthritis Patients and their Relatives  The Open Rheumatology Journal, 2011, Volume 5   37 
  Here it is timely to recall the following well known facts. 
First, along with neutrophils monocytes - macrophages are 
key actors in antiinfectious host defense [10]. Second, innate 
immunity, with macrophages playing a central role, is 
critically important in the pathogenesis of RA [9, 12]. Third, 
in the overwhelming majority of the RA cases the disease 
sneaks up insensibly, so the mentioned above “rheumatoid” 
phenotype of monocytes in predisposed to the disease 
individuals may develop long before the first joint symptoms 
as a result of frequent and prolonged common infections in 
particular. 
  Thus, the comparison of the monocyte functioning in RA 
patients and in their predisposed to the disease relatives (the 
cells of women, not hereditary tainted with autoimmune 
diseases, being a control), may be useful for the solving the 
problem of RA provocation. 
MATERIALS AND METHODOLOGY 
  The research project was approved by the Kazan State 
Medical Academy Ethics Committee (State registration N 
01200502513) and was conducted in accordance with the 
declaration of Helsinki and the Russian National Health and 
Medical Research Council statement on human experimentation. 
Subjects 
  For the current experimental series we have selected 24 
female patients (Ps), aged 45,6±12,8 years with advanced 
RA (7,3±3,5 years of disease duration, Table 1), 24 first 
degree maternal relatives (Rs) of these patients (average age 
39,9±10,6 years) and 24 assumed to be healthy women 
without inherited predisposition to autoimmune diseases had 
an average age 40,7±15,7 years (control group, Ds). 
  Groups of RA patient, their relatives and donors 
underwent routine clinical and paraclinical examination to 
reveal the inflammatory syndrome (ESR, leukocyte count, 
C-RP, fibrinogen), the autoimmune syndrome (IgM-, IgG-, 
IgA- rheumatoid factors, anticitrulline antibodies, 
anticardiolipin antibodies, antiDNA antibodies, complement, 
circulating immune complexes, immunoglobulins), as well 
as a magnetic resonance imaging (relatives) and a X-ray 
photograph (RA patients), microbial analysis - bacterial 
seedings of nasopharyngeal, urinal, vaginal and gut common 
microflora. 
  All the Ps received DMARD supporting therapy: 
methotrexate 19 (79,2%), leflunomide 4 (16,7%), and 1 P - 
sulfasalazine (4,1%), intraarticular corticosteroids during 
exacerbation of RA (~40% of P). In the RA group selected 
for the current experimental series there were no cases of the 
evident relationship between infectious syndrome 
development and specific immunosuppressive therapy 
(exclusion test). 
  The selected group of first degree female relatives 
comprised of 17 daughters, 6 sisters and 1 woman, who 
happened to be both a sister and a daughter of an RA patient. 
Fifteen (62,5%) of them had shared epitope (HLA 
DRB1*04,04; *04,01; or *04, or *01) in genome, 
rheumatoid factors were transiently revealed in 13 (54,2%) 
while antibodies against citrullinated peptides in 12 (50,0%) 
of them. 
  Not a singlee diagnostic laboratory RA marker or a 
positive paraclinical sign of inflammation was revealed in 
the control group. 
 Methods.  The cell and serum samples were taken for 
investigations in the period between the infectious episodes 
in the absence of clinical signs of infection (in all groups) 
and with no paraclinical signs of inflammation (in relative 
and control groups). 
  Mononuclear Phagocyte (MP) Isolation Peripheral 
blood MPs were isolated using a universally accepted 
method of Ficoll – Urografin density gradient separation 
[13]. 
  Engulfment and Digestion Functions of MP were 
estimated within 24 hours using a radioisotope method. We 
reproduced the classic experiments, performed by J. 
Schmidtke and E. Unanue with some our modifications [14]. 
The object of phagocytosis (OP) - Staphylococcus aureus 
strain Wood was grown in the media with 
14C - labeled 
amino acids and opsonized with pooled native sera (blood 
group IV). The OP suspension was added to MP suspension 
to provide 10
3 microbial bodies per cell with the following 
incubation after that at 37
0C for 30 minutes, and after that 
the unbound material was removed by centrifugation. Then 
the cells were washed twice. 
  The first cell measurements were done immediately 
following the 30 minute incubation, the next - in 2, 4, and 24 
hours of incubation at 37
0C. The cells incubated for further 
2, 4 and 24 hours were then centrifuged and washed twice to 
remove all accumulated products of digestion from 
suspensions. Thus, each tested MP sample contained only 
those digestion products that had accumulated within a 
certain time period. The supernatants received following the 
first 30 minutes of incubation with labeled bacteria contained 
OP both unbound to the cells and already degraded ones. 
Therefore the intensity of digestion of labeled bacterial 
proteins by the cells to low-molecular weight peptides 
(LMP) during this time was assessed as a value difference 
between the radioactivity of cell suspension supernatants and 
bacteria suspension supernatants after treatment of them both 
with 20% trichloroacetic acid. As to high molecular weight 
degraded products (HMP), this value was not taken into 
consideration, since it was not possible to determine the parts 
of OP, unbound to the cells and those already digested. 
  After cell sedimentation the following samples were 
measured using Beta analyzer (POMA, Kiev, Ukraina): (a) 
the total cell - bound radioactivity of the label; (b) the 
intracellular radioactivity of the label (following the removal 
of surface membrane proteins by trypsin treatment); (c) the 
radioactivity of the supernatants (HML and LMP - bound 
label); (d) the radioactivity of the LMP - bound label (after 
HMP precipitation by 20% trichloroacetic acid). The 
measured values were expressed in CPM – count per minute. 
Under the selected experimental conditions the MP counts 
were not essentially decreased in the samples, and their 
viability estimated by trypan blue staining was 95 - 98%. 
  FITC-labeled aggregated human immunoglobulin 
(Agg-Ig-FITC) engulfment was estimated in 30 minutes 
after incubation of MP with Agg-Ig-FITC (1,25 μg/ml of 
protein per 10
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FITC and membrane associated proteins by trypsin treatment 
of the cells the fluorescence of intracellular Agg-Ig-FITC 
was measured (ex = 492 , em = 518 ), using a MPF 
44B spectrofluorimeter (Perkin Elmer, USA). 
  Release of lysosomal glucuronidase from MP in the 
first 30 minutes of the cell incubation with opsonized 
zymosan (OZ) was estimated by fluorescence of the 
hydrolysis product of MUF -  - glucuronide (Sigma, USA), 
that is a fluorescent analog of the glucuronidase substrate. 
Measurements were made using a MPF 44B 
spectrofluorimeter (Perkin Elmer, USA) at ex = 325 nm. The 
substrate content was defined at em = 448 nm, while the 
product - at em = 375 nm. The intensity of glucuronidase 
release was calculated as the ratio product/substrate 
fluorescence intensity measured before and 0.5, 15 and 30 
minutes after OZ addition (arbitrary units, au). To exclude 
the possible cellular uptake of the MUF--glucuronide and 
its intracellular cleavage we sedimented the cells after 
incubation with fluorescent probe and measured the 
fluorescence of the pellets and supernatants. These control 
experiments showed, that the substrate and the product were 
only revealed in the supernatants, but not in the cells. 
  Treatment of the MPs with phagocytosis modulators. 
In some experiments we treated the MPs with 50 μM 
vinblastine (Sigma, USA) for 30 minutes, or 0,1 mM 
isoniazid (Sigma, USA) for 1,5 hours (25
0) before OZ 
addition. The intact MPs (as a control) were incubated 
without modulators but in the same conditions. 
  Reactive oxygen species (ROS) generation by the MPs 
was estimated by luminol-dependent chemiluminescence 
technique. Chemiluminometer designed at the KSMA by Dr. 
Zinkevich O.D. was used. Real time registration was 
performed every 4 sec in the thermostated chamber with 
continuous mixing of the cell suspension (sample volume 
was 3 ml, cell density – 3x10
6 per ml, and concentration of 
OZ was 0.1 mg/ml). The following parameters were 
measured (arbitrary units, au): the spontaneous level of ROS 
production, total ROS production estimated as an area under 
the curve of time – chemiluminescence intensity dependence 
within 30 minutes after OZ addition. 
  Serum cytokine levels were measured by ELISA method 
using monoclonal antibodies against tumor necrosis factor 
Table 1.  Characteristics of the Patients in the Advanced RA group (n=24) 
 
Criteria Number  (%) 
Slowly progressing  20 (83,3) 
Quickly progressing  3 (12,5) 
With no marked progression  1 (4,2) 
Progressing 
Initial manifestation  0 
There are 
2 (8,3) 
(rheumatoid nodules in anamnesis) 
Extraarticular 
manifestations 
There are no  22 (91,7) 
RF positive  24 (100,0) 
RF negative  0 
antiCCP positive  18 (75,0) 
Immunologic characteristics 
antiCCP negative  6 (25,0) 
There are  17 (70,8) 
Shared Epitopes 
There are no  7 (29,2) 
Minimal 10  (41,7) 
Moderate 14  (58,3) 
Activity 
(DAS28-ESR) 
High 0 
I 0 
II 0 
III 18  (75,0) 
 
Roentgenologic stage 
IV 6  (25,0) 
0 4  (16,7) 
I 14  (58,3) 
II 6  (25,0) 
III 0 
Joint functional deficiency (HAQ) 
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alpha (TNF-alpha) and interleukin 1 beta (IL-1beta) (“Vector 
–best”, Russia). 
 Statistic  analysis was made using with Student’s t-test 
for dependent samples, Mann - Whitney test, Kruskal - 
Wallis test. 
RESULTS 
  Reliable differences (p<0,05) were revealed while 
studying the process of OP engulfment in all the groups 
(Table  2, Fig. 1). In the Ds the amount of 
14- bacterial 
particles engulfed by MPs was almost at the peak in the first 
30 minutes of the experiment, while in the Ps the ingestion 
was maximal at the interval of 2 - 4 hours from the 
beginning of the process. During this time the amount of 
material engulfed by the D cells was already decreasing 
(Table 2). Yet, despite the delayed engulfment the patient 
MPs were already actively digesting during the first half an 
hour of the experiment (Table 2). The amounts of LMP in 
cell suspension supernatants of the Ps and the Ds were nearly 
identical in this time interval. Supernatants obtained 2 hours 
later with a reliably (Mann - Whitney test, p<0,05) lower 
amount of the engulfed material in the MPs of the Ps showed 
the same similar values of LMP radioactivity, while the 
HMP value was 1.5 times higher in this group than the 
control one (Table 2). 
  In the Rs as well as in the Ps the process of engulfment of 
the labeled bacterial particles was also slowed down, but it 
was also distinctly decreased (Table 2, Fig. 1). Yet, in this 
group as well, the LMP radioactivity in supernatants 
significantly exceeded the background level after 30 minutes 
from the beginning of the experiment; 2 hours later it   
 
approximated the control value, while the HMP content was 
even somewhat higher during this time interval (Table 2). 
 
Fig. (1). Radioactivity of the intracellular label in the MP of RA 
patients (P, n=24), female relatives (R, n=24), and healthy women - 
donors (D, n=24), not hereditary tainted with autoimmune diseases 
(average values±SD, * - reliable difference when compared to D 
group values for the same time interval, p0,05; complete data are 
shown in Table 1). 
 
Table 2.  The Radioactivity of the Label, Bound with the Mononuclear Phagocytes (MP), Low-Molecular Weight Products (LMP) 
and High-Molecular Weight Products (HMP) in the Investigated Time Intervals in the Groups of RA Patients (P), Female 
Relatives (R), and Healthy Women - Donors (D), Not Hereditary Tainted with Autoimmune Diseases, M±SD (CPM) 
 
Time Intervals, Hour 
Radioactivity
3  Group 
0,5  2  4  24 
Intracellular label  348,09±353  365,28±42 
*309,44±54 
*106,65±573 
Membrane label 
D 
1293,89±989 
*687,91±245 
*324,89±824 
*186,02±874 
Intracellular label 
^79,28±59 
^*124,83±392 
*346,83±2 
^*52,58±59 
Membrane label 
P 
1299,63±523 
^*783,96±663 
^*52,57±9 
^*121,82±59 
Intracellular label 
^80,96±72 
^*145,62±82 
^*201,07±32 
^*82,48±843 
Membrane label 
R 
^1637,80±754 
^*803,41±292 
^*228,68±53 
^*128,07±97 
D  1650,3±101,9
1  285,04±32,8  227,29±17,6 
*77,46±9,9 
P  1910,6±99,9
1  ^443,65±31,9 
*177,56±11,5 
*57,43±12,9  HMP 
R  1595±21,9
1  ^388,61±23,3 
^*139,05±10,7 
*34,159±18,5 
D 215,79±10,09
2  221,32±12,6 173,82±11,7 
*117,48±19,6 
P 202,43±9,8
2  210,09±7,09 
^*306,90±21,8 
^*53,70±10,7  LMP 
R 
^158,70±8,9
2 *197,55±12,7 218,91±11,2 
^*64,33±14,6 
1The index was not taken into consideration (the explanation - in Materials). 
2The difference between radioactivity of cell suspension supernatants and that of bacterial suspension supernatants added to the cell samples. 
3Background radioactivity 16,19±6,9 CPM. 
*Reliable difference when compared to previous time interval index in the group (Student T-test, p<0,05) 
^Reliable difference when compared to D group values for the same time interval (Student's and Mann - Whitney test, p<0,05) 40   The Open Rheumatology Journal, 2011, Volume 5  Arleevskaya et al. 
  Besides, while estimating the summary values of HMP 
(except 0-0,5 hour interval index) and LMP within the time 
of the experiment it turned out, that the digestive activity of 
the R MPs (1201,31 ± 15,68 CPM) was reliably (Mann - 
Whitney test, p<0,05) lower as compared to that in the Ds 
(1318,25±25,67 CPM). The highest digestive activity of MP 
was observed in the P group (1451,76 ± 33,02 CPM). 
  Thus, it is of interest to note the fact that despite a small 
amount of labeled material present inside the cells the MPs 
of the Ps and, to a lesser degree, - of the Rs were already 
actively digesting in the first 2 hours of the experiment. 
  We hypothesized that during this period the digestion 
predominantly occurs extracellulary due to lysosomal 
enzyme release into the environment. 
  To test this hypothesis we studied the release of 
lysosomal enzyme -glucuronidase - during the interaction 
between the MPs and OZ. Since the hydrolysis products of 
the labeled substrate were registered in the cell samples of all 
3 groups the extracellular cleavage of MUF-glucuronide is 
not likely to be a true pathologic process. However, the 
accumulation of the product in the Ps cell suspensions was 
reliably (Kruskal-Wallis test, p<0,05) more marked at all 
time periods after OZ addition (Fig. 2). The intensity of this 
process in the Rs also reliably exceeded the control values. 
  To test the suggested model of MP dysfunction in the Ps 
and the Rs we studied the influence of the well known 
modulators of phagocytosis – vinblastine, an inhibitor of 
cytoskeleton assemble, and isoniazid, an agent facilitating 
lysosome – phagosome fusion, on the Agg-Ig-FITC 
engulfment and lysosomal glucuronidase release (Fig. 3). 
  The intensity of fluorescence of Agg-Ig-FITC engulfed 
by the Ps MPs of the (114,6±9,1 a.u.) and the Rs (110,5±8,9  
 
 
Fig. (2). The intensity of fluorescence of glucuronidase – MUF--
glucuronide cleavage products in the MP supernatants of advanced 
RA patients (P, n=24), female relatives (R, n=24), and healthy 
women, not hereditary tainted with autoimmune diseases - donors 
(D, n=24) (average values±SD are shown, * - reliable difference 
when compared to D group values for the same time interval, 
p0,05). 
a.u.) was reliably lower (Mann-Whitney test, p<0,05) after 
30 minute incubation, than that in the D group (196,5±8,7 
au), these results were compatible with the data obtained 
from the experiments with 
14C – Staphylococcus aureus 
engulfment. Vinblastine treatment resulted in (i) a reliable 
 
Fig. (3). The influence of vinblastin (VB) and isoniaside (IS) to the intensity of fluorescence of glucuronidase – MUF -  - glucuronide 
cleavage products in the MP supernatants of RA patients (P, n=24), female relatives (R, n=24), and healthy women, not hereditary tainted 
with autoimmune diseases (D, n=24) (* - reliable differences when compared to intact MPs (INT), p0,05). Mononuclear Phagocytes in Rheumatoid Arthritis Patients and their Relatives  The Open Rheumatology Journal, 2011, Volume 5   41 
(Mann-Whitney test, p<0,05) decrease of the Agg-Ig-FITC 
engulfment, as compared to the untreated samples – 2,9 
times lower in the D cell suspensions (68,7±10,2 au), 3,5 
times lower in the P cell suspensions (32,3±3,8 au) and 3,6 
times lower in R cell suspensions (31,0±2,9 au), while there 
was a (ii) reliable (Mann-Whitney test, p<0,05) rise in the 
product / substrate fluorescence intensity ratio in all three 
groups (Fig. 3). These results were rather anticipated since 
inhibition of enclosed phagosome formation gave rise to the 
enhancement of lysosomal glucoronidase release. 
  The influence of isoniazid was revealed only in the P and 
R groups as a reliable (Mann-Whitney test, p<0,05) increase 
of the ratio product/substrate fluorescence intensity ratio in 
the treated cell samples as compared to those in untreated 
MP samples (Fig. 3). In the D group there was no influence 
of isoniazid on the ratio of product/substrate fluorescence 
intensity in the MP samples, which seems to be natural since 
lysosomal glucuronidase release following OZ engulfment 
by MPs of the Ds primarily occurred into the enclosed 
phagosomes. 
  The spontaneous levels of ROS generation (Fig. 4a) by 
the P (3,6±2,1 au) and the R (3,5±2,6 au) MPs were almost 
twice as much as compared to that in the control group 
(1,7±0,8 au), although the difference was found to be 
nonreliable (Mann - Whitney test, p>0,05). Total ROS 
generation in the respiratory burst induced by opsonized 
zymosan (Fig. 4b) was reliably (Mann - Whitney test, 
p<0,05) higher in the Ps (333,9±127,9 au) than that in the Ds 
(76,4±35,7 au), and the highest values were revealed in the 
Rs (1197,9±464,1 au). The increased stimulated ROS 
generation by the MPs of RA patients was anticipated due to 
the cell priming in chronic rheumatoid inflammation. As to 
the relatives, we assume that the excessive oxygen radical 
production in response to MP stimulation may be a result of 
the pro-inflammatory effect on the cells during frequent and 
prolonged infectious episodes observed in the RA–
predisposed relatives [15]. 
  The average serum levels of the cytokines in the P (TNF-
alpha 82,1±77,1 pg/ml, IL-1beta 48,8±31,3 pg/ml) and the R 
(TNF-alpha 125,9±100,1 pg/ml, IL-1beta 41,8±35,3 pg/ml) 
were reliably increased as compared to the controls (TNF-
alpha 0,9±0,7 pg/ml, IL – 1beta 0,7±0,4 pg/ml) (Mann - 
Whitney test, p<0,05). The increased levels of one or both 
cytokines were revealed in 74% of the Ps and in 75% of the 
Rs and none in the donors. For the Ps the results were 
anticipated since the high levels of these cytokines are the 
well known hallmark of the disease [16, 17]. As to the R 
group the high levels of pro-inflammatory cytokines – the 
well known stimulators of the MPs, support our suggestion, 
that the Rs cells are primed. On the other hand the high 
levels of these factors may be the signs of the MP activation, 
at least the circulating monocytes in RA are the main source 
of serum TNF-alpha and IL-1 [18-22]. 
  No influence of clinical parameter of RA or disease 
specific therapy on the MP functions under study was found. 
DISCUSSION 
  The delayed formation of the phagosomes due to the 
slowed down engulfment of the objects of phagocytosis by 
the mononuclear phagocytes of the RA patients results in 
their unclosed form development and in the lysosomal 
enzyme release into the extracellular environment. This 
peculiarity of the cell functioning probably resulting in 
preferentially extracellular digestion seems to be the 
characteristic feature of the mononuclear phagocytes in RA 
patients and individuals predisposed to the disease. The cell 
digestive activity, probably inhibited in predisposed to RA 
female relatives, becomes abundant after the disease onset; 
ROS generation by the mononuclear phagocytes is increased 
both in patients and their relatives. 
  The delayed engulfment may be due to a RA specific set 
of expressed membrane receptors. In our experiments we 
treated the MPs either with Staphylococcus aureus or with 
zymosan (both of them were opsonized by native serum), or 
with Agg- IgG-FITC. Thus, in vitro cell stimulation occurred 
primarily through Fc –, C3b –, mannose binding, Toll – like 
1, 2/6 receptors [23, 24]; while the cells condition in the two 
experimental groups was different from that in the control 
group, as the patient’s MPs and probably those of the 
relatives were primed. The results of many investigations 
showed that the expression of various MP receptors was 
adequate to stimuli levels in rheumatoid arthritis both in sera 
and synovial fluid [25-29]. Thus, one might expect that the 
increased expression of membrane receptors in patients may 
result in more rapid and efficient engulfment and digestion. 
Therefore, in our opinion, the revealed MP functioning 
 
Fig. (4). ROS generation by the MPs of RA patients (P), female relatives (R), and healthy women, not hereditary tainted with autoimmune 
diseases - donors (D) (
1 - reliable difference when compared with D group values (Mann - Whitney criteria)). 42   The Open Rheumatology Journal, 2011, Volume 5  Arleevskaya et al. 
peculiarities in the Ps and, possibly, in the Rs are unlikely to 
be due to the abnormal membrane receptor sets. 
  Earlier we tried to analyze whether various MP function 
activation in RA corresponds to various stimuli levels in 
vascular bed and joint tissues [30]. The conclusions of the 
review were the following. 
  Firs, the main properties of monocytes in the vascular 
bed in RA are the ongoing priming and chemotaxis towards 
the sites of inflammation – joint tissues, and arriving to the 
inflammatory sites they realize their potential as phagocytic  
and cytotoxic cells. It is well known that the processes of 
chemotaxis and engulfment are in feedback relationship [31]. 
In our experiments we picked out the circulating monocytes 
and placed them in the conditions similar to those in the 
inflammatory sites by adding aggregated IgG or opsonized 
bacteria or zymosan. This sudden change of environment 
may be a cause of delayed engulfment since the cells have no 
time enough to reorganize the intracellular machinery from 
the chemotactic behavior to the phagocytic one. 
  Second, we assumed that a number of signs in RA can be 
estimated as manifestation of impaired relationship between 
some MP separate functions [30]. The discordance of 
decreased engulfment and enhanced digestion and ROS 
generation revealed for the MPs in RA is totally consistent 
with this speculation. This imbalance is probably not true 
pathologic, since the capacity to express particular functions 
changes during the cell maturation. For example, immature 
cells are highly phagocytic but on receiving a maturation 
stimulus they lose this capacity [24]. 
  On the other hand, there are some data, indicating that 
impaired relationship between separate MP functions may be 
due to the altered functioning of the intracellular signal 
network or plasma membrane. It was shown, for example, 
that among the “silent” genes in the RA patients there are 
also genes of some factors, involved in the process of actin 
polymerization [32]. It is also known, that in RA patients the 
antibodies to cytoskeletal elements (actin and myosin) are 
often revealed [33]. Actin is also one of the non-histone 
targets for histone deacetylases – the enzyme the activity of 
which is supposed to be impaired in RA patients [34, 35]. 
  The other players in the process of phagosome closure 
are membrane lipids involved in receptor cupping, 
pseudopod extension and signal transduction [36]. We have 
already revealed higher viscosity of cellular membrane of the 
MPs in RA patients and their relatives (unpublished data). 
  There are some well known remarkable facts. Toll-like 
receptor mediated cell activation of the cells mainly results 
in cytokine secretion. Though the expression of these 
receptors on monocytes is not disturbed in RA, they are 
known to have higher responsiveness to the ligands, as 
compared to the cells of osteoarthritis patients and healthy 
controls [37, 38]. This may be due, for example, to some 
peculiarities in intracellular signal transduction. 
  It is also known, that Fc – receptor mediated 
phagocytosis is more dependent on actin polymerization and 
membrane lipid reorganization processes. Thus, taking to 
consideration the possible problems with actin 
polymerization and membrane functioning peculiarity 
together with enhanced responsiveness to the Toll-like 
receptor stimulation, the revealed changes of the MP 
functioning in the Ps might be the result of the shift of the 
cell functions from the process of phagocytosis to cytokine 
production. 
  The current experimental series is a part of a long-term 
(more than 10 years) cohort study of RA and common 
infections interplay (the results are in press). The dynamic of 
the annual incidence and duration of the common focal 
infections was analyzed in groups of 306 RA patients, 242 
their first degree female relatives and 214 women not 
hereditary tainted with autoimmune diseases. It turned out 
that despite the vigorous suppressive therapy with cytostatics 
and sometimes with corticosteroids the annual incidence and 
duration of common infectious episodes in the Ps were close 
to those in the Ds. At the same time in the R group the focal 
common infections were 2,1 times more often and 2,6 times 
more prolonged than that in the control group. In the R group 
the infectious syndrome mainly comprised chronic tonsillitis 
(51.7%), exacerbations of which were severe in this group – 
with fever, purulent plugs in tonsils, and in some cases – 
with the peritonsillar abscess development. Purulent 
bronchitis (48.3%), acute respiratory – viral infections 
(44.8%), furunculosis and staphylococcus skin lesion 
(27.6%) were less frequent. Some other focal infections 
occurred as well: those of otorhinologic organs, of upper 
respiratory and urinary tracts, the frequency of which was 
similar to that in Ds. 
  It should be pointed out that the cell and serum samples 
were taken from the subjects without any clinical sign of 
infection in all 3 groups and negative paraclinical markers of 
inflammation in the Rs and the Ds. 
  So the data received in the group of prone to RA relatives 
are rather intriguing. High levels of pro-inflammatory 
cytokines, presumably, of monocyte origin, and increased 
stimulated ROS generation may be the signs of prolonged 
cell activation in the R group even in the absence of the most 
probable causes for cell stimulation. Here the delayed 
engulfment leading to predominantly extracellular digestion 
due to lysosomal enzyme release into the environment seems 
to be the specific feature of the MPs in this group as well. Of 
course it may be due to the nature of cell stimulation, similar 
to that in RA group. Yet it may be the sign of some 
hereditary problems in MP functioning as well! 
  In the predisposed to RA relatives the delayed and 
suppressed engulfment associated with the decelerated 
digestive potential of the mononuclear phagocyte may be 
one of the causes of the infectious syndrome. At the same 
time in rheumatoid arthritis patients the accelerated digestive 
potential together with the slowed down process of 
engulfment and predominantly extracellular digestion may 
contribute to the massive tissue damage fraught with 
development of immune reactions to self antigens. 
CONCLUSION 
  We show for the first time that the functioning of 
circulating mononuclear phagocytes in the assumed to be 
healthy predisposed to RA individuals differs from that in 
the healthy people not hereditary tainted with autoimmune 
diseases and in general resembles the functioning of the cells 
in the patients with advanced RA. Mononuclear Phagocytes in Rheumatoid Arthritis Patients and their Relatives  The Open Rheumatology Journal, 2011, Volume 5   43 
SUMMARY 
  Monocyte functions: engulfment, digestion, ROS 
generation, lysosomal enzyme release into environment, and 
serum cytokine levels were compared in RA patients and 
their relatives. 
ABBREVIATIONS 
Agg-Ig-FITC  =  FITC-labeled aggregated human  
     immunoglobulins  
a.u.   =  Arbitrary units  
CPM   =  Counts per minute 
Ds  = donors – Healthy women, not hereditary   
     tainted with autoimmune diseases  
HMP  =  High molecular weight peptides 
IL-1 =  Interleukin 1 beta  
LMP  =  Low-molecular weight peptides 
MPs =  Mononuclear  phagocytes 
OP  =  Objects of phagocytosis 
OZ =  Opsonized  zymosan 
Ps =  Rheumatoid  arthritis  patients 
Rs  =  First degree maternal female relatives of  
     RA patients 
RA =  rheumatoid  arthritis 
ROS  =  Reactive oxygen species 
TNF- =  Tumor necrosis factor alpha  
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